NCT06140745 - Evaluation of Dentifrice Formulations to Remineralize Enamel and Dentine Subsurface Lesions in a Double-Blind In-Situ Clinical Trial | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 5, 2020

Primary Completion Date

February 21, 2021

Study Completion Date

February 21, 2021

Conditions

Caries

Interventions

DRUG

0 ppm Fluoride Dentifrice 1

Each subject will use this product during one of the five treatment periods in the crossover study design.

DRUG

1100 ppm NaF Fluoride Dentifrice

Each subject will use this product during one of the five treatment periods in the crossover study design.

DRUG

1500 ppm NaMFP Fluoride Dentifrice

Each subject will use this product during one of the five treatment periods in the crossover study design.

DRUG

0 ppm Fluoride Dentifrice 2

Each subject will use this product during one of the five treatment periods in the crossover study design.

DRUG

0 ppm Fluoride Dentifrice 3

Each subject will use this product during one of the five treatment periods in the crossover study design.

Trial Locations (1)

University of Melbourne, Melbourne

All Listed Sponsors

lead

Procter and Gamble

INDUSTRY